Stroke in thyrotoxicosis with atrial fibrillation

Area of Science:

• Cardiology
• Endocrinology
• Neurology

Background:

• Chronic atrial fibrillation is a known stroke risk factor.
• Atrial fibrillation is common in elderly patients with thyrotoxicosis, but stroke risk is debated.
• Thyrotoxicosis management requires understanding associated cardiovascular risks.

Purpose of the Study:

• To investigate the independent risk of cerebrovascular events in patients with untreated thyrotoxicosis.
• To determine the role of atrial fibrillation as a predictor of stroke in this population.
• To evaluate the necessity of prophylactic anticoagulation for stroke prevention in thyrotoxic atrial fibrillation.

Main Methods:

• Retrospective study of 610 patients with initially untreated thyrotoxicosis.
• Logistic regression analysis to assess risk factors including age, sex, and atrial fibrillation.
• Focus on cerebrovascular event risk within the first year post-thyrotoxicosis diagnosis.

Main Results:

• Atrial fibrillation was present in 14.9% of patients, more frequent in the elderly.
• Age was a significant independent risk factor for cerebrovascular events (p < 0.005).
• Sex and atrial fibrillation were not significant independent risk factors (p = 0.09 and p = 0.17, respectively).

Conclusions:

• Age, not atrial fibrillation, was the primary risk factor for stroke in thyrotoxicosis patients in this cohort.
• Findings contradict previous studies on thyrotoxic atrial fibrillation and stroke risk.
• The indication for prophylactic anticoagulation in thyrotoxic atrial fibrillation appears questionable without controlled trial data.